Published in
Taylor and Francis Group, Expert Review of Hematology, p. 1-14, 2023
DOI: 10.1080/17474086.2023.2276206
Links
Tools
Etranacogene dezaparvovec for the treatment of adult patients with severe and moderately severe hemophilia B
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 